NDRA

3.5753.38%
ZR

Ziad Rouag

Head of Regulatory & Clinical Affairs

Mr. Ziad Rouag, JD, is Regulatory Advisor of Voxel Systems LLC. Mr. Rouag is Head of Regulatory and Clinical Affairs of ENDRA Life Sciences Inc. from August 2024. Mr. Rouag served as President and Chief Executive Officer at SIMARATO SAS (formerly known as Biomodex). Mr. Rouag has experience in the medical device industry as a leader of clinical operations and regulatory affairs for emerging startups and high-growth businesses. Prior to Biomodex, Mr. Rouag served as Vice President of Regulatory and Clinical Affairs at several companies including Juul Labs, PQ Bypass and Altura Medical. He served as Vice President of Regulatory, Quality and Clinical Affairs with Auxogyn, Inc. Mr. Rouag was held several positions with various medical device companies, serving as Vice President of Regulatory, Quality and Clinical Affairs with Avinger, Regulatory Affairs Director with Evalve Inc. (an Abbott Laboratories acquisition); Regulatory Affairs Director with Johnson & Johnson; and Regulatory and Clinical Director with Guidant Corporation. He holds BA from McGill University. Mr. Rouag holds B.S. degrees in Biology and Economics from McGill University, Montreal Canada and a J.D. from Rutgers University, Camden New Jersey.

Positions